20/20 Biolabs, Inc. (AIDX)
0.5139
-0.04
(-7.29%)
USD |
NASDAQ |
Aug 24, 16:00
0.5139
0.00 (0.00%)
After-Hours: 20:00
20/20 Biolabs Price to Book Value : 3.885 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 4.190 |
| August 20, 2026 | 3.886 |
| August 19, 2026 | 3.845 |
| August 18, 2026 | 3.901 |
| August 17, 2026 | 4.160 |
| August 14, 2026 | 4.15 |
| August 13, 2026 | 3.920 |
| August 12, 2026 | 3.485 |
| August 11, 2026 | 3.289 |
| August 10, 2026 | 3.457 |
| August 07, 2026 | 3.441 |
| August 06, 2026 | 3.416 |
| August 05, 2026 | 3.336 |
| August 04, 2026 | 3.447 |
| August 03, 2026 | 3.219 |
| July 31, 2026 | 3.213 |
| July 30, 2026 | 3.032 |
| July 29, 2026 | 3.313 |
| July 28, 2026 | 3.439 |
| July 27, 2026 | 3.403 |
| July 24, 2026 | 3.712 |
| July 23, 2026 | 3.870 |
| July 22, 2026 | 4.151 |
| July 21, 2026 | 4.141 |
| July 20, 2026 | 3.870 |
| Date | Value |
|---|---|
| July 17, 2026 | 3.913 |
| July 16, 2026 | 4.005 |
| July 15, 2026 | 4.172 |
| July 14, 2026 | 4.15 |
| July 13, 2026 | 4.307 |
| July 10, 2026 | 4.453 |
| July 09, 2026 | 4.407 |
| July 08, 2026 | 4.37 |
| July 07, 2026 | 4.423 |
| July 06, 2026 | 4.717 |
| July 02, 2026 | 4.649 |
| July 01, 2026 | 4.607 |
| June 30, 2026 | 4.155 |
| June 29, 2026 | 2.442 |
| June 26, 2026 | 2.453 |
| June 25, 2026 | 2.415 |
| June 24, 2026 | 2.319 |
| June 23, 2026 | 2.573 |
| June 22, 2026 | 2.503 |
| June 18, 2026 | 2.687 |
| June 17, 2026 | 2.638 |
| June 16, 2026 | 2.352 |
| June 15, 2026 | 2.437 |
| June 12, 2026 | 3.938 |
| June 11, 2026 | 3.518 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Sanara MedTech, Inc. | 39.74 |
| Intelligent Bio Solutions, Inc. | 1.323 |
| Anteris Technologies Global Corp. | 3.408 |
| Quest Diagnostics, Inc. | 3.569 |
| Labcorp Holdings, Inc. | 3.192 |
Price to Book Value Related Metrics
| PS Ratio | 2.782 |
| Price | 0.5139 |
| Earnings Yield | -140.7% |
| Market Cap | 6.296M |